LRCX
Lam Research Corporation NASDAQ Listed May 4, 1984$286.61
After hrs
$294.78
+0.25%
Mkt Cap $358.4B
52w Low $74.65
94.9% of range
52w High $298.00
50d MA $239.13
200d MA $176.89
P/E (TTM)
61.6x
EV/EBITDA
19.5x
P/B
33.5x
Debt/Equity
0.5x
ROE
55.3%
P/FCF
23.1x
RSI (14)
—
ATR (14)
—
Beta
1.79
50d MA
$239.13
200d MA
$176.89
Avg Volume
10.5M
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
4650 Cushing Parkway · Fremont, CA 94538 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | AMC | 1.36 | 1.47 | +8.1% | 265.55 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% | — |
| Jan 28, 2026 | AMC | 1.17 | 1.27 | +8.5% | 239.58 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% | — |
| Oct 22, 2025 | AMC | 1.22 | 1.26 | +3.3% | 141.25 | -2.3% | +4.5% | +7.4% | +11.1% | +10.2% | +13.7% | — |
| Jul 30, 2025 | AMC | 1.21 | 1.33 | +9.9% | 99.09 | -8.1% | -4.3% | -2.7% | -0.7% | -2.4% | -3.2% | — |
| Apr 23, 2025 | AMC | 1.00 | 1.04 | +4.0% | 66.73 | +4.4% | +6.2% | +7.0% | +7.3% | +6.2% | +7.4% | — |
| Jan 29, 2025 | AMC | 0.88 | 0.91 | +3.6% | 75.15 | +6.1% | +7.4% | +7.9% | +6.7% | +6.3% | +9.0% | — |
| Oct 23, 2024 | AMC | 0.81 | 0.86 | +6.2% | 72.86 | +4.6% | +5.1% | +6.6% | +3.6% | +7.5% | +4.9% | — |
| Jul 31, 2024 | AMC | 0.76 | 0.81 | +6.9% | 92.12 | -7.2% | -9.9% | -17.2% | -16.4% | -16.4% | -18.8% | — |
| Apr 24, 2024 | AMC | 7.30 | 0.78 | -89.3% | 88.49 | +2.8% | +1.9% | +4.6% | +5.0% | +1.1% | -1.9% | — |
| Jan 24, 2024 | AMC | 0.71 | 0.75 | +5.6% | 84.82 | +3.4% | +2.1% | -1.1% | -0.3% | -1.5% | -2.7% | — |
| Oct 18, 2023 | AMC | 0.61 | 0.69 | +13.1% | 64.22 | -2.4% | -6.3% | -6.5% | -6.6% | -5.9% | -9.2% | — |
| Jul 26, 2023 | AMC | 0.50 | 0.60 | +20.0% | 64.24 | +5.1% | +9.3% | +12.3% | +11.8% | +11.4% | +6.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5 | Seaport Research Partners | Initiates | Buy | $300 | $258.57 | $266.64 | +3.1% | +6.7% | +14.9% | +10.8% | — | — |
| Apr 23 | Needham | Maintains | Buy → Buy | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | TD Cowen | Maintains | Buy → Buy | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | Stifel | Maintains | Buy → Buy | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | Citigroup | Maintains | Buy → Buy | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | BofA Securities | Maintains | Buy → Buy | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | RBC Capital | Maintains | Outperform → Outperform | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | Evercore ISI | Maintains | Outperform → Outperform | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 23 | JP Morgan | Maintains | Overweight → Overweight | — | $265.55 | $265.05 | -0.2% | -2.6% | +0.8% | -2.3% | -5.4% | -6.3% |
| Apr 9 | Susquehanna | Maintains | Positive → Positive | — | $246.49 | $248.33 | +0.7% | +5.0% | +7.0% | +8.5% | +10.5% | +7.6% |
| Apr 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $218.44 | $220.13 | +0.8% | +1.0% | +2.7% | +12.8% | +18.5% | +20.7% |
| Mar 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $211.15 | $211.00 | -0.1% | +1.9% | +3.7% | -0.8% | +0.5% | +3.9% |
| Feb 25 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $244.25 | $249.89 | +2.3% | +2.1% | -2.1% | -4.2% | -5.4% | -11.0% |
| Jan 29 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Susquehanna | Maintains | Positive → Positive | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Goldman Sachs | Maintains | Buy → Buy | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Needham | Maintains | Buy → Buy | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | UBS | Maintains | Buy → Buy | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Stifel | Maintains | Buy → Buy | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Evercore ISI | Maintains | Outperform → Outperform | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | Citigroup | Maintains | Buy → Buy | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | RBC Capital | Maintains | Outperform → Outperform | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 29 | JP Morgan | Maintains | Overweight → Overweight | — | $239.58 | $245.61 | +2.5% | +3.6% | -2.6% | -0.9% | -4.0% | -12.4% |
| Jan 22 | Citigroup | Maintains | Buy → Buy | — | $228.39 | $235.56 | +3.1% | -3.4% | -4.6% | -2.4% | +4.4% | +4.9% |
| Jan 21 | Deutsche Bank | Maintains | Buy → Buy | — | $222.41 | $223.05 | +0.3% | +2.7% | -0.8% | -2.0% | +0.2% | +7.2% |
| Jan 20 | UBS | Maintains | Buy → Buy | — | $222.96 | $218.21 | -2.1% | -0.2% | +2.4% | -1.0% | -2.3% | -0.0% |
| Jan 20 | Needham | Maintains | Buy → Buy | — | $222.96 | $218.21 | -2.1% | -0.2% | +2.4% | -1.0% | -2.3% | -0.0% |
| Jan 15 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $208.79 | $228.15 | +9.3% | +4.2% | +6.8% | +6.5% | +9.4% | +5.7% |
| Jan 14 | Stifel | Maintains | Buy → Buy | — | $214.38 | $211.13 | -1.5% | -2.6% | +1.4% | +4.0% | +3.7% | +6.5% |
| Jan 13 | BofA Securities | Maintains | Buy → Buy | — | $220.40 | $219.42 | -0.4% | -2.7% | -5.3% | -1.3% | +1.2% | +0.9% |
| Jan 12 | Bernstein | Maintains | Outperform → Outperform | — | $218.36 | $216.12 | -1.0% | +0.9% | -1.8% | -4.4% | -0.4% | +2.1% |
| Jan 9 | Mizuho | Maintains | Outperform → Outperform | — | $200.96 | $204.66 | +1.8% | +8.7% | +9.7% | +6.7% | +3.9% | +8.2% |
| Jan 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $203.08 | $202.87 | -0.1% | -1.0% | +7.5% | +8.5% | +5.6% | +2.8% |
| Dec 23 | UBS | Maintains | Buy → Buy | — | $175.26 | $175.26 | +0.0% | -0.1% | +1.2% | +1.6% | +0.3% | -0.8% |
| Dec 18 | B. Riley Securities | Maintains | Buy → Buy | — | $154.98 | $163.19 | +5.3% | +6.3% | +11.2% | +13.1% | +13.0% | +14.4% |
| Dec 17 | Mizuho | Maintains | Outperform → Outperform | — | $163.26 | $163.86 | +0.4% | -5.1% | +0.9% | +5.5% | +7.4% | +7.3% |
| Dec 15 | Jefferies | Maintains | Buy → Buy | — | $160.52 | $163.40 | +1.8% | +2.4% | +1.7% | -3.5% | +2.6% | +7.3% |
| Dec 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $154.79 | $155.85 | +0.7% | +2.2% | +3.2% | +1.5% | +2.5% | +5.1% |
| Nov 25 | UBS | Maintains | Buy → Buy | — | $150.38 | $149.54 | -0.6% | +1.0% | +3.2% | +3.7% | +2.9% | +5.2% |
| Nov 12 | Citigroup | Maintains | Buy → Buy | — | $159.18 | $161.31 | +1.3% | +1.4% | -3.7% | -6.9% | -7.4% | -10.0% |
| Oct 23 | Needham | Maintains | Buy → Buy | — | $141.25 | $138.00 | -2.3% | +4.5% | +7.4% | +11.1% | +10.2% | +13.7% |
| Oct 23 | Oppenheimer | Maintains | Outperform → Outperform | — | $141.25 | $138.00 | -2.3% | +4.5% | +7.4% | +11.1% | +10.2% | +13.7% |
| Oct 23 | Mizuho | Maintains | Outperform → Outperform | — | $141.25 | $138.00 | -2.3% | +4.5% | +7.4% | +11.1% | +10.2% | +13.7% |
| Oct 23 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $141.25 | $138.00 | -2.3% | +4.5% | +7.4% | +11.1% | +10.2% | +13.7% |
| Oct 23 | B. Riley Securities | Maintains | Buy → Buy | — | $141.25 | $138.00 | -2.3% | +4.5% | +7.4% | +11.1% | +10.2% | +13.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Fernandes Neil JOff | Senior Vice President | Sell | 18,170 | $255.14 | $4.6M | 66,129 | +6.66% | — |
| Apr 27, 2026 | Harter AvaOff | Chief Legal Officer | Sell | 6,010 | $258.66 | $1.6M | 53,205 | -0.99% | +10.34% |
8-K
Lam Research Corp -- 8-K Filing
Lam Research Corporation released its Q3 2026 financial results, showing the semiconductor equipment manufacturer's operational performance for the quarter ended March 29, 2026.
Apr 22
8-K · 5.02
!!! Very High
Lam Research Corp -- 8-K 5.02: Executive Change
Tim Archer's appointment as Lam Research CEO signals continuity in semiconductor equipment leadership, which should reassure investors about stable strategic direction and operational execution during industry cyclical transitions.
Feb 4
8-K · 5.02
!!! Very High
Lam Research Corp -- 8-K 5.02: Executive Change
Lam Research's executive departure signals potential leadership instability during a cyclical downturn in semiconductor equipment demand, which could concern investors about operational continuity and strategic direction.
Feb 3
Data updated apr 25, 2026 7:51pm
· Source: massive.com